FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental medicine, and can be used to simulate the microbiota of the chicken cecum in artificial intestinal systems. First, into a flask containing a nutrient medium composition with the ratio of ingredients, g/l: starch - 0.5-2.5 g, isolated soy protein - 10-20 g, unrefined sunflower oil - 10-30 ml, MgSO4 - 0.25-1.5 g, NaCl - 3-6 g, K2HPO4 - 0.25-1.5 g, MnSO4 - 0.05-0.06 g, FeSO4 - 0.05-0.06 g, Tween 80 - 0.5-1.5 ml, water up to 1 l, a defrosted starter is introduced from the contents of the caecum of chickens containing microorganisms, and incubated in an anaerobic chamber under conditions corresponding to the simulated area of the intestine. Then the test sample is placed in the reactor - a model of artificial chicken intestine, while setting the temperature and gas conditions corresponding to the specified conditions.
EFFECT: method provides an opportunity to simulate the microbiota of the chicken caecum in artificial systems by developing a model of the artificial chicken intestine, including the composition of the artificial intestinal medium, where a “starter” is added containing microbial cultures that normally colonize the chicken digestive tract, and a nutrient medium for the growth of the microbiota, which makes it possible to take into account the influence of microbiota in the systems of the artificial digestive tract of chicken, to evaluate the effect of additives on the intestinal microbiota, and to screen the properties of probiotic strains.
1 cl, 2 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF THE ARTIFICIAL INTESTINAL MEDIUM FOR THE STUDY OF THE MICROBIOTA OF THE CAECUM OF CHICKEN | 2021 |
|
RU2772350C1 |
ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON BACTERIAL STRAIN | 2015 |
|
RU2616899C1 |
METHOD FOR TREATMENT OF IRRITABLE BODY SYNDROME | 2017 |
|
RU2661624C1 |
LEVILACTOBACILLU BREVIS “ВКШМ-Г-07ПД” BACTERIA STRAIN | 2024 |
|
RU2821556C1 |
ISOLATED MICROBIAL STRAIN OF LACTOBACILLUS PLANTARUM TENSIA DSM 21380 AS ANTIMICROBIAL AND HYPOTENSIVE PROBIOTIC, FOOD PRODUCT AND COMPOSITION CONTAINING SAID MICROORGANISM, AND USE OF SAID MICROORGANISM TO OBTAIN HYPOTENSIVE MEDICINAL AGENT, METHOD OF INHIBITING PATHOGENS AND SECONDARY LACTIC BACTERIA IN FOOD PRODUCT | 2009 |
|
RU2477750C2 |
METHOD FOR PRODUCTION OF DIETARY SUPPLEMENT | 2007 |
|
RU2346463C2 |
METHOD OF PREPARING HOMOPROBIOTIC BACTERIAL PREPARATION CONTAINING LIVING LACTIC BACTERIA | 1999 |
|
RU2146288C1 |
BREAST MILK OLIGOSACCHARIDE (BMO) MIXTURES FOR USE IN INFANTS OR YOUNG CHILDREN IN MEDICAL PURPOSES | 2018 |
|
RU2773404C2 |
SYNERGETIC PRODUCTION OF BUTYRATE RELATED TO COMPLEXITY OF BMO MIXTURE FOR USE IN INFANTS OR YOUNG CHILDREN FOR MEDICAL PURPOSES | 2018 |
|
RU2769462C2 |
PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
Authors
Dates
2022-05-30—Published
2021-09-18—Filed